These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 23847445)
21. Ectopic overexpression of COTE1 promotes cellular invasion of hepatocellular carcinoma. Zhang H; Huang CJ; Tian Y; Wang YP; Han ZG; Li XC Asian Pac J Cancer Prev; 2012; 13(11):5799-804. PubMed ID: 23317259 [TBL] [Abstract][Full Text] [Related]
22. MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4. Zhao Y; Li F; Zhang X; Liu A; Qi J; Cui H; Zhao P Int J Clin Exp Pathol; 2015; 8(10):12446-54. PubMed ID: 26722431 [TBL] [Abstract][Full Text] [Related]
23. MicroRNA-33b suppresses the proliferation and metastasis of hepatocellular carcinoma cells through the inhibition of Sal-like protein 4 expression. Tian Q; Xiao Y; Wu Y; Liu Y; Song Z; Gao W; Zhang J; Yang J; Zhang Y; Guo T; Dai F; Sun Z Int J Mol Med; 2016 Nov; 38(5):1587-1595. PubMed ID: 28026002 [TBL] [Abstract][Full Text] [Related]
24. Treatment with MAPKAP2 (MK2) inhibitor and DNA methylation inhibitor, 5-aza dC, synergistically triggers apoptosis in hepatocellular carcinoma (HCC) via tristetraprolin (TTP). Tran DDH; Koch A; Allister A; Saran S; Ewald F; Koch M; Nashan B; Tamura T Cell Signal; 2016 Dec; 28(12):1872-1880. PubMed ID: 27619201 [TBL] [Abstract][Full Text] [Related]
25. Effects of LncRNA-HOST2 on cell proliferation, migration, invasion and apoptosis of human hepatocellular carcinoma cell line SMMC-7721. Liu RT; Cao JL; Yan CQ; Wang Y; An CJ; Lv HT Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28143959 [TBL] [Abstract][Full Text] [Related]
26. Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma. Ikeguchi M; Ueta T; Yamane Y; Hirooka Y; Kaibara N Clin Cancer Res; 2002 Oct; 8(10):3131-6. PubMed ID: 12374680 [TBL] [Abstract][Full Text] [Related]
27. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway. Li WF; Dai H; Ou Q; Zuo GQ; Liu CA Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417 [TBL] [Abstract][Full Text] [Related]
28. NKD1 correlates with a poor prognosis and inhibits cell proliferation by inducing p53 expression in hepatocellular carcinoma. Zhang S; Li J; Wang X Tumour Biol; 2016 Oct; 37(10):14059-14067. PubMed ID: 27507614 [TBL] [Abstract][Full Text] [Related]
29. RMP predicts survival and adjuvant TACE response in hepatocellular carcinoma. Zhang J; Jiang TY; Jiang BG; Yang C; Tan YX; Yang N; Pan YF; Ding ZW; Yang GZ; Wu MC; Dong LW; Wang HY Oncotarget; 2015 Feb; 6(5):3432-42. PubMed ID: 25605019 [TBL] [Abstract][Full Text] [Related]
30. Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma. Chiba T; Saito T; Yuki K; Zen Y; Koide S; Kanogawa N; Motoyama T; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Otsuka M; Miyazaki M; Iwama A; Yokosuka O Int J Cancer; 2015 Jan; 136(2):289-98. PubMed ID: 24844570 [TBL] [Abstract][Full Text] [Related]
32. Silencing non-SMC chromosome-associated polypeptide G inhibits proliferation and induces apoptosis in hepatocellular carcinoma cells. Liu K; Li Y; Yu B; Wang F; Mi T; Zhao Y Can J Physiol Pharmacol; 2018 Dec; 96(12):1246-1254. PubMed ID: 30089216 [TBL] [Abstract][Full Text] [Related]
33. [Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2]. Xu JY; Chen LB; Xu JY; Yang Z; Wei HY; Xu RH Ai Zheng; 2006 May; 25(5):526-32. PubMed ID: 16687068 [TBL] [Abstract][Full Text] [Related]
34. Clinical and biological significance of transcription termination factor, RNA polymerase I in human liver hepatocellular carcinoma. Komatsu H; Iguchi T; Ueda M; Nambara S; Saito T; Hirata H; Sakimura S; Takano Y; Uchi R; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Eguchi H; Doki Y; Mori M; Mimori K Oncol Rep; 2016 Apr; 35(4):2073-80. PubMed ID: 26821084 [TBL] [Abstract][Full Text] [Related]
35. MiR-451a suppresses cell proliferation, metastasis and EMT via targeting YWHAZ in hepatocellular carcinoma. Wei GY; Hu M; Zhao L; Guo WS Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5158-5167. PubMed ID: 31298411 [TBL] [Abstract][Full Text] [Related]
36. Hypermethylation of FOXD3 suppresses cell proliferation, invasion and metastasis in hepatocellular carcinoma. He G; Hu S; Zhang D; Wu P; Zhu X; Xin S; Lu G; Ding Y; Liang L Exp Mol Pathol; 2015 Oct; 99(2):374-82. PubMed ID: 26112097 [TBL] [Abstract][Full Text] [Related]
37. Cyclin B2 Overexpression in Human Hepatocellular Carcinoma is Associated with Poor Prognosis. Li R; Jiang X; Zhang Y; Wang S; Chen X; Yu X; Ma J; Huang X Arch Med Res; 2019 Jan; 50(1):10-17. PubMed ID: 31101236 [TBL] [Abstract][Full Text] [Related]
38. PYCR1 interference inhibits cell growth and survival via c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathway in hepatocellular cancer. Zhuang J; Song Y; Ye Y; He S; Ma X; Zhang M; Ni J; Wang J; Xia W J Transl Med; 2019 Oct; 17(1):343. PubMed ID: 31619254 [TBL] [Abstract][Full Text] [Related]
39. [Effect of TUTF1 expression on the proliferation, apoptosis and prognosis of hepatocellular carcinoma cells]. Li ZJ; Li JS; Li DY; Pu T Zhonghua Gan Zang Bing Za Zhi; 2019 Nov; 27(11):879-884. PubMed ID: 31941243 [No Abstract] [Full Text] [Related]
40. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis. Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]